AI-based quantification of TILs using hematoxylin and eosin and immunohistochemistry-stained slides in triple-negative breast cancer.

被引：0
|
作者：
Kobayashi, Takuma
Tomioka, Nobumoto
Hatanaka, Kanako C.
Konishi, Teppei
Grynkiewicz, Mateusz
Komura, Daisuke
Ishikawa, Shumpei
Watanabe, Kenichi
Takahashi, Masato
Hatanaka, Yutaka
机构：
[1] Biomy Inc, Tokyo, Japan
[2] Natl Hosp Org NHO Hokkaido Canc Ctr, Dept Breast Surg, Sapporo, Hokkaido, Japan
[3] Hokkaido Univ Hosp, Ctr Dev Adv Diagnost, Sapporo, Hokkaido, Japan
[4] Univ Tokyo, Dept Prevent Med, Grad Sch Med, Tokyo, Japan
[5] NHO Hokkaido Canc Ctr, Dept Breast Surg, Sapporo, Hokkaido, Japan
[6] Hokkaido Univ Hosp, Dept Breast Surg, Sapporo, Hokkaido, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13608
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Are we overtreating stage I triple-negative breast cancer in Ontario? A population-based retrospective epidemiological analysis using the ICES database
    Kathryn Shum
    Abdulkadir Hussein
    Caroline Hamm
    Medical Oncology, 39
  • [32] Predicting Response of Triple-Negative Breast Cancer to Neoadjuvant Chemotherapy Using a Deep Convolutional Neural Network-Based Artificial Intelligence Tool
    Krishnamurthy, Savitri
    Jain, Parag
    Tripathy, Debu
    Basset, Roland
    Randhawa, Ramandeep
    Muhammad, Hassan
    Huang, Wei
    Yang, Hua
    Kummar, Shivaani
    Wilding, George
    Roy, Rajat
    JCO CLINICAL CANCER INFORMATICS, 2023, 7
  • [33] Are we overtreating stage I triple-negative breast cancer in Ontario? A population-based retrospective epidemiological analysis using the ICES database
    Shum, Kathryn
    Hussein, Abdulkadir
    Hamm, Caroline
    MEDICAL ONCOLOGY, 2022, 39 (12)
  • [34] Comparison of Lysis and Detachment Sample Preparation Methods for Cultured Triple-Negative Breast Cancer Cells Using UHPLC-HRMS-Based Metabolomics
    Rushing, Blake R.
    Schroder, Madison
    Sumner, Susan C. J.
    METABOLITES, 2022, 12 (02)
  • [35] The TILs-US score adding vascularity assessment based on ultrasonography for predicting tumor-infiltrating lymphocytes in human epidermal growth factor receptor 2-positive and triple-negative breast cancer
    Kimura, Yuri
    Masumoto, Norio
    Akashi-Tanaka, Sadako
    Fukui, Kayo
    Noma, Midori
    Nagata, Aya
    Nakamura, Takashi
    Shima, Hiroaki
    Okuno, Toshitaka
    Murakami, Akari
    Kamei, Yoshiaki
    Nakano, Shogo
    Arihiro, Koji
    CANCER RESEARCH, 2023, 83 (05)
  • [36] Designing a novel SOX9 based multi-epitope vaccine to combat metastatic triple-negative breast cancer using immunoinformatics approach
    HemaNandini Rajendran Krishnamoorthy
    Ramanathan Karuppasamy
    Molecular Diversity, 2023, 27 : 1829 - 1842
  • [37] Germline pathogenic variants associated with triple-negative breast cancer in US Hispanic and Guatemalan women using hospital and community-based recruitment strategies
    Godinez Paredes, Jesica M.
    Rodriguez, Isabel
    Ren, Megan
    Orozco, Anali
    Ortiz, Jeremy
    Albanez, Anaseidy
    Jones, Catherine
    Nahleh, Zeina
    Barreda, Lilian
    Garland, Lisa
    Torres-Gonzalez, Edmundo
    Wu, Dongjing
    Luo, Wen
    Liu, Jia
    Argueta, Victor
    Orozco, Roberto
    Gharzouzi, Eduardo
    Dean, Michael
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 205 (03) : 567 - 577
  • [38] Designing a novel SOX9 based multi-epitope vaccine to combat metastatic triple-negative breast cancer using immunoinformatics approach
    Krishnamoorthy, HemaNandini Rajendran
    Karuppasamy, Ramanathan
    MOLECULAR DIVERSITY, 2023, 27 (04) : 1829 - 1842
  • [39] Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database
    Zhong-Li Du
    Yang Wang
    Ding-Yuan Wang
    Li Zhang
    Zhi-Min Bian
    Ying Deng
    Cheng-Shan Xu
    Dong-Cai Lin
    Li Xie
    Yao Jia
    Ji-Dong Gao
    Bai-Lin Zhang
    Breast Cancer Research and Treatment, 2020, 183 : 429 - 438
  • [40] A novel approach for targeted elimination of CSPG4-positive triple-negative breast cancer cells using a MAP tau-based fusion protein
    Amoury, Manal
    Mladenov, Radoslav
    Nachreiner, Thomas
    Anh-Tuan Pham
    Hristodorov, Dmitrij
    Di Fiore, Stefano
    Helfrich, Wijnand
    Pardo, Alessa
    Fey, Georg
    Schwenkert, Michael
    Thepen, Theophilus
    Kiessling, Fabian
    Hussain, Ahmad F.
    Fischer, Rainer
    Kolberg, Katharina
    Barth, Stefan
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (04) : 916 - 927
12345